Evaxion A (EVAX) Net Income (2020 - 2026)
Evaxion A's (EVAX) quarterly Net Income came in at -$4.1 million in Q1 2026, down 106.77% YoY from $60.0 million in Q1 2025, and up 36.83% on a QoQ basis from -$6.4 million in Q4 2025.
Evaxion A (EVAX) Net Income (2020 - 2026) Analysis & Trends
Evaxion A (EVAX) has 7 years of Net Income data on file, last reported at -$4.1 million in Q1 2026.
- Quarterly Net Income fell 106.77% year-over-year to -$4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.6 million (up 20.75% YoY) and the FY2025 annual result came in at -$9.5 million, up 21.58% from the prior year.
- Net Income grew to -$4.1 million in Q1 2026, from -$6.4 million in the prior quarter.
- In the past five years, Net Income ranged from a high of $5.8 million in Q1 2022 to a low of -$7.2 million in Q4 2022.
- A 5-year average of -$3.1 million and a median of -$4.9 million in 2023 frame the typical range for Net Income.
- The widest YoY moves for Net Income: up 292.15% in 2025, down 359.1% in 2025.
- Tracing EVAX's Net Income over 5 years: stood at -$7.2 million in 2022, then soared by 32.43% to -$4.9 million in 2023, then climbed by 14.31% to -$4.2 million in 2024, then tumbled by 53.84% to -$6.4 million in 2025, then surged by 36.83% to -$4.1 million in 2026.
- The last three Net Income figures came in at -$4.1 million (Q1 2026), -$6.4 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -13.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | 81.49 Mn |
| 10 | Evaxion A | 27.69 Mn | 27.69 Mn | - | -4.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.06 Mn |
| Dec 31, 2025 | -6.43 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Jun 30, 2025 | -5.22 Mn |
| Mar 31, 2025 | -1.96 Mn |
| Dec 31, 2024 | -4.18 Mn |
| Sep 30, 2024 | -2.13 Mn |
| Jun 30, 2024 | -6.40 Mn |
| Mar 31, 2024 | 758,000.00 |
| Dec 31, 2023 | -4.88 Mn |
| Sep 30, 2023 | -6.07 Mn |
| Jun 30, 2023 | -6.13 Mn |
| Mar 31, 2023 | -6.63 Mn |
| Dec 31, 2022 | -7.22 Mn |
| Sep 30, 2022 | -6.09 Mn |
| Jun 30, 2022 | 4.77 Mn |
| Mar 31, 2022 | 5.79 Mn |
| Dec 31, 2021 | -5.72 Mn |
| Sep 30, 2021 | 16.16 Mn |
| Jun 30, 2021 | 10.91 Mn |